Table of Contents
Current Status of Global Recognition and Acceptance of Traditional Chinese Medicine
The status of traditional Chinese medicine in the global healthcare field is undergoing a revolutionary upgrade, and its cognitive scope has expanded from traditional Chinese communities to mainstream social groups. At present, traditional Chinese medicine services have covered 196 countries and regions worldwide, forming a multi-level and differentiated international acceptance map. The recognition and application characteristics of traditional Chinese medicine in different regions show distinct regional features, which are closely related to the local cultural background, policy support, and historical origins.
1.1 Asia region: high recognition under cultural homogeneity
In the Asian region, traditional Chinese medicine has gained widespread recognition based on similar cultural and philosophical foundations
Japan: Chinese herbal medicine has been included in the national health insurance system, covering 210 effective prescriptions and 140 types of raw medicines, establishing a mature Chinese herbal medicine industry system (about 200 pharmaceutical factories, over 2000 formulations). The Japanese market has a high dependence on Chinese medicinal herbs, with ginseng being its largest imported variety. In 2024, the import value reached 42.56 million US dollars, a year-on-year increase of 15.2%.
South Korea: Legislation establishes equal status between Korean medicine and Western medicine, with approximately 10000 students studying Chinese medicine in China each year. South Korea has become China’s second largest export market for medicinal herbs, with an annual trade volume of nearly 150 million US dollars.
ASEAN countries: Vietnam, Malaysia, Thailand and other regions are actively promoting localized planting. The “Lancang Mekong River Basin Traditional Medicine Planting Base” (20000 acres) jointly built by China and Cambodia is under construction, and the Cambodian people’s acceptance of Chinese herbal medicine treatment is constantly increasing.
1.2 Developed Countries in Europe and America: Legislative Breakthroughs and Mainstream Processes
The acceptance of traditional Chinese medicine in Western countries has made significant breakthroughs in recent years:
Australia (the world’s first country to legislate traditional Chinese medicine): It has 4800 registered Chinese medicine practitioners, over 5000 Chinese medicine clinics, and serves 2.8 million people annually, with 80% of patients being English native speakers.
United States: 47 states legislate to legalize acupuncture and moxibustion, with more than 45000 acupuncture and moxibustion, and about 4 million people receive acupuncture and
moxibustion treatment every year. The government invests 120 million US dollars annually to support supplementary medical research.
EU: Hungary will first issue an EU license for traditional Chinese medicine practice; Germany has one traditional Chinese medicine clinic for every 15000 people; Switzerland has included traditional Chinese medicine in its basic medical insurance through a nationwide referendum.
1.3 Emerging markets and other regions
In emerging markets such as Brazil and Cuba, traditional Chinese medicine has also made breakthrough progress:
In 2006, the Ministry of Health of Brazil incorporated acupuncture and moxibustion and herbal medicine into the public medical system
Cuba regards TCM acupuncture and moxibustion as the main treatment within the medical insurance system
Central and Eastern Europe accelerates the construction of traditional Chinese medicine centers through the “16+1 cooperation” mechanism
Table: Characteristics of the Top 10 Countries and Regions with the Highest Global Recognition of Traditional Chinese Medicine
National/regional legislative progress, application characteristics, market size/coverage
Australia was included in the health industry registration management system in 2012, with a high acceptance rate of 5000+clinics and an annual service of 2.8 million people
In 1976, Japan included Chinese herbal medicine preparations in its health insurance, which had a high degree of standardization and accounted for 25.4% of China’s medicinal exports
In 1951, South Korea’s legislative status was equivalent to that of Western medicine, and the Korean medical education system was improved, with an annual import value of 150 million US dollars
Acupuncture and moxibustion legalization is dominated by acupuncture and moxibustion in 47 states of the United States, and hospitals set up acupuncture and moxibustion departments to serve 4 million person times annually
Hungary issues EU medical license in 2016, leading 300+products with EU certification for traditional Chinese medicine, and obtaining EU sales license
Germany has a high penetration rate of formal medical education clinics, accounting for 16.7% of the total number of doctors
Switzerland included basic medical insurance coverage in 2009, with a nationwide referendum support rate of 67%
Self discipline management of British industry acupuncture and moxibustion with outstanding characteristics 3000+TCM clinics
Brazil included primary healthcare applications in public healthcare in 2006, with a public hospital penetration rate of 60%
The Cambodia China Cambodia Traditional Chinese Medicine Center has been established to promote localized planting and advance the preparation of the Lancang Mekong Base
Diversification of Application Scenarios and Industrial Innovation
The international application of traditional Chinese medicine is expanding from traditional medicine to multiple fields, forming a composite industry form of “medical+health+consumption”. The diversification of this application scenario has become the core driving force for global market growth.
2.1 Medical Application Extension and Evidence Based Medicine Breakthrough
Modern traditional Chinese medicine continuously expands its medical application boundaries through evidence-based medicine research
Chronic disease management: Tsumura Pharmaceutical establishes KAMPOmics in Japan ® The interdisciplinary research system verifies the mechanism of action of Chinese herbal medicine through modern technological means such as metabolomics and genetic research, and promotes the product to enter the Japanese disease diagnosis and treatment guidelines.
Assistive treatment for difficult diseases: German traditional Chinese medicine hospitals have made breakthroughs in the field of tumor adjuvant therapy, and traditional Chinese medicine has gained clinical recognition in reducing the side effects of radiotherapy and chemotherapy.
Standardized production innovation: Leading enterprises apply mixed batch technology for medicinal herbs and monitor indicator components to solve the problem of inter batch differences in natural medicinal herbs. Jincun Company has established a full process quality control system from planting to processing through the GACP standard, ensuring the safety, effectiveness, and consistency of its products.
2.2 “Same origin of medicine and food” leads the wave of healthy consumption
The cross-border application of traditional Chinese medicine has become a breakthrough point for international market growth:
Functional food: Gansu Province has developed a product matrix that combines medicine and food (Angelica sinensis tea drink, Codonopsis pilosula soup, goji berry brewing), promoting a year-on-year increase of 24.8% in export value in the first quarter of 2025. Guizhou Chishui Dendrobium Juice and Dendrobium Tea have become local specialty drinks, while Jiangkou County Poria Noodles and Epimedium Tea have entered the Singapore market.
Organic herbal dietary supplements: The global market size is expanding at a compound annual growth rate of 12.52%, and is expected to reach 461.27 billion dollars in 2032. The field of immune enhancement accounts for the largest share (35%), while the weight management field has the fastest growth rate (an annual increase of 15%).
Youth Health Trend: Generation Z is driving the explosion of innovative products, such as goji berry latte, cinnamon cappuccino, and other “Chinese medicine+coffee” mixed drinks that have become popular in Europe and America. The recipe for Ume Soup has exceeded 100 million views on TikTok. The millennial group has the highest acceptance of convenient forms such as herbal gummies and ready to drink dendrobium freeze-dried powder.
2.3 Integration of Traditional Chinese Medicine Beauty and Ecology
In the fields of beauty and personal care, the natural properties of traditional Chinese medicine are in line with the global trend of “pure beauty”:
Ganoderma lucidum and ginseng essence become high-end anti-aging ingredients, and licorice extract is used in soothing skin care products
Chinese herbal bath products have passed the EU ECOCERT certification, and Yao bath medicine bags have become popular souvenirs for tourism in Congjiang
Combining traditional Chinese medicine cultivation with ecological tourism, the 8000 acre Gouteng Base in Qingyun Town, Guizhou Province has developed sightseeing agriculture, driving an average income increase of 7000 yuan per household
Table: Growth Trends in Segmented Fields of the Global Herbal Market (2024-2032 Forecast)
Market size of segmented areas in 2024 (in billions of dollars) and forecast for 2032 (in billions of dollars). Main driving factors for compound annual growth rate
Type of herbal medicine
Ayurvedic medicine 68.2 188.5 13.5% revival of traditional Indian medicine
Traditional Chinese Medicine 53.1 151.2 14.0% Increased International Influence in China
Herbal dietary supplements 41.3 112.8 13.4% young people’s health needs
Application field
Immune enhancement 63.4 170.8 13.1% post epidemic health concerns
Weight Management 39.2 121.5 15.2% Increase in Obesity Rate
Pain management 28.7 75.4 12.8% alternative opioid drugs
Stress and sleep 25.1 62.3 12.0% urban psychological sub-health
consumer group
Generation Z (18-25 years old) 32.7 102.4 15.4% social media influence
Millennials (26-40 years old) 58.9 152.6 12.6% Work Stress Health Preservation
Baby Boomer Generation (55+) 42.3 98.5 11.1% Chronic Disease Management Needs
3 Market Data and Prospect Forecast
The global Chinese herbal medicine market is undergoing structural changes, showing a development trend of import growth and export optimization. Driven by multiple factors such as aging population, upgrading health consumption, and technological innovation, the market potential continues to be released.
3.1 Import and export pattern and competitive situation
The international trade of traditional Chinese medicine in 2024 presents a distinct asymmetry:
The export market fluctuated and adjusted: the annual export value was 1.2 billion US dollars, a year-on-year decrease of 5.7%. The traditional Asian market share has shrunk, with the Vietnamese market plummeting by 45.6% (mainly due to a sharp decline in cinnamon exports), and Hong Kong and Singapore experiencing a decline of over 20%. The proportion of high value-added products exports has increased, with the export value of Angelica sinensis reaching 41.15 million US dollars (an increase of 27.0%) and Pinellia ternata increasing by 12.1%.
The demand for imports continues to expand: the import volume has reached a historic high (640 million US dollars, an increase of 3.6%), with an import volume of 339000 tons. Indonesia, Vietnam, and India are the main source countries (accounting for 42.5% of the market share). The import of characteristic varieties has surged, with clove imports increasing by 230.1% and fat sea imports increasing by 393.3%.
Regional competitiveness reconstruction: Guangdong, Tianjin, and Guangxi form an export “golden triangle”, accounting for over 50% of the country’s exports. Tianjin has performed outstandingly, with its export value climbing from 120 million US dollars in 2022 to 150 million US dollars in 2024. Shanxi pharmaceutical companies leverage ASEAN cooperation to upgrade from traditional Chinese medicine materials to formulations through Zhendong Pharmaceutical and other enterprises.
3.2 Market size and growth drivers
The global Chinese herbal medicine market has entered a scale of billions and maintained strong growth:
The global market size is expected to reach 91.6 billion US dollars in 2023, and is expected to exceed 200 billion RMB (approximately 28 billion US dollars) by 2025, with a compound annual growth rate of nearly 10%.
The organic herbal medicine segment is growing faster, expected to increase from $179.53 billion in 2024 to $461.27 billion in 2032, with a CAGR of 12.52%.
Triple engine drives market expansion:
Population structure change: More than 10% of the global population aged 65 and above, and the demand for chronic disease management is released. China has 267 million people over 60 years old. Traditional Chinese medicine plays a prominent role in the prevention and treatment of diabetes and cardiovascular and cerebrovascular diseases.
Policy dividend release: The China ASEAN Traditional Chinese Medicine Industry Alliance has been established, the General Administration of Customs has expanded the “List of Access for Medicinal Materials of Animal and Plant Origin”, and the facilitation level of customs clearance for Chinese medicinal materials has been improved.
Perfect logistics network: China Europe regular train and China Laos railway reduce cross-border transportation costs, and the upgrading of ASEAN cold chain logistics system helps the export of fresh medicinal materials.
3.3 Analysis of Regional Development Potential
In the next decade, the global traditional Chinese medicine market will present a multipolar development pattern:
Asia Pacific led: accounting for 65% of global demand, China implements the revitalization and development project of traditional Chinese medicine, and Shanxi creates a cluster of authentic medicinal herbs (with the highest production of Astragalus membranaceus, Codonopsis pilosula, and Forsythia suspensa in the country). The Indian Ayurvedic medicine market is growing at an annual rate of 15%.
Innovation in North America: Focusing on scientific research transformation, research investment in plant medicines such as American ginseng and cranberry has increased by 12% annually. The reform of health care product registration system accelerates the listing of Chinese herbal dietary supplements.
EU Upgrade: Traditional Herbal Medicine Registration Directive (THMPD) promotes standardization, with Germany investing 300 million euros to build a plant medicine research center.
Figure: Growth Curve of Global Traditional Chinese Medicine Market Size from 2022 to 2032 (Regional Forecast)
(Unit: Billion US Dollars)
Year: North America, Europe, Asia Pacific, and other regions
2022 14.2 12.8 32.5 3.1
2024 18.3 15.6 45.7 4.2
2026 23.7 19.2 61.3 5.5
2028 30.6 23.5 78.9 7.1
2030 39.5 28.8 98.5 9.2
2032 50.9 35.1 120.2 11.8
Data source: Global Organic Herbal Market Report
4 Challenges and Response Strategies
Despite its broad prospects, the globalization of traditional Chinese medicine still faces triple challenges in terms of resources, standards, and cognition. Cracking these challenges requires collaborative innovation across all links of the industrial chain.
4.1 Resource Sustainability Crisis
The depletion of rare medicinal herbs has become the primary bottleneck restricting the development of the industry
The price of natural bezoar is 1.7 million yuan/kg, musk is over 600000 yuan/kg, and wild cordyceps is 20000 to 30000 yuan/kg.
The trade of endangered species such as rhino horns and tiger bones has been completely banned, but black market transactions still carry risks.
Response strategy:
Research and development of artificial substitutes: Breakthrough in artificial breeding technology for Saiga antelope horns, alleviating pressure on wild resources
Overseas planting expansion: Chinese enterprises establish 100000 acres of planting bases in Indonesia and Laos to reduce dependence on wild medicinal herbs
Circular economy model: Gansu Province establishes a full industry chain of “planting processing waste fertilization”, increasing the utilization rate of medicinal materials to 90%
4.2 Standards and Quality Barriers
The lack of unified quality standard system is the main obstacle to the internationalization of traditional Chinese medicine
The EU’s Traditional Plant Medicine Directive requires a 15 year history of use to prove that most traditional Chinese medicines are difficult to meet
Testing by Tsumura Company in Japan shows that the effective ingredients of the same medicinal herb fluctuate by up to 30% in different production areas
Leading Enterprise Practice:
Jinchun GACP standard: Establish a full process quality control covering soil selection, planting, and harvesting, with pesticide residue control three times stricter than the Chinese Pharmacopoeia
People who read this article also viewed walnuts
Lanzhou Customs’ ‘Quality Prediction Model’: Establishing a Standardized Planting System for Exported Medicinal Materials through the Study of the Connection of Central European Pharmacopoeia Standards
Central Six Provinces Alliance: Shanxi, Anhui and other provinces jointly build a high-quality development alliance for traditional Chinese medicine, unifying the standards for authentic medicinal materials
4.3 Cultural cognitive differences
Insufficient theoretical recognition of traditional Chinese medicine in the Western healthcare system:
The US FDA classifies traditional Chinese medicine as a “dietary supplement” and restricts claims of medical efficacy
The EU only approves 7 registrations of traditional Chinese medicine (compared to Japan approving 210 Chinese herbal medicines)
The way to break through:
Evidence based Medicine Research: Kimura KAMPOmics ® The system analyzes the mechanism of action of the compound through metabolomics analysis
Localized dissemination: 80% of Australian traditional Chinese medicine practitioners treat non Chinese populations and explain the concept of “qi and blood” using Western medical terminology
Integrated traditional and western medicine: Germany included acupuncture and moxibustion in the treatment guidelines for low back pain, and verified the effect of meridian stimulation with MRI images
5 Development Suggestions and Future Prospects
Based on the development trends and challenges of the global traditional Chinese medicine market, the future development of the industry needs to focus on three core strategies and build a sustainable development path for the internationalization of traditional Chinese medicine.
5.1 Industry Chain Integration and Value Enhancement
Breaking the fragmented state of the industrial chain and achieving full value chain optimization:
Upstream standardization: Establish a cross-border GACP planting base network, promote the “customized medicinal garden” model in Shanxi (Yuanzhi accounts for 70% of the national production), and advance the “one product, one source” traceability system for medicinal materials.
Midstream technology empowerment: By applying AI breeding and blockchain traceability technology, Jincun has developed a mixed batch system for medicinal materials to improve batch consistency.
Downstream branding: Zhendong Pharmaceutical promotes the upgrading of “traditional Chinese medicine → formulation → brand” in ASEAN, and Anhui Bozhou builds the “World Capital of Traditional Chinese Medicine” (with an annual transaction volume accounting for 50% of the country’s total).
5.2 Evidence based medicine and standard construction
Cracking the scientific challenges of traditional Chinese medicine requires breakthroughs in modern research methods
Accelerate clinical verification: carry out multicenter RCT test, and give priority to acupuncture and moxibustion, chronic kidney disease and other fields to establish the evidence chain of efficacy.
Research on the Mechanism of Component Action: Drawing on KAMPOmics ® Technical route, using systems biology to analyze the synergistic effects of compound formulas.
International standard leadership: Promote the implementation of ISO/TC249 Chinese herbal medicine standards, and add 7 international standards such as ginseng and Sanqi in 2024.
5.3 Ecological Protection and Innovative Applications
Balancing industrial development and resource conservation, exploring green growth paths:
Rare species replacement project: Dendrobium officinale tissue culture technology (yield increased by 30 times), industrialization of artificial musk.
Innovation of medicinal food homology: Gansu Province has developed a functional beverage of Codonopsis pilosula (with an annual export growth of 40% to Singapore), and the added value of processed goji berries has increased fivefold.
Circular economy model: Guizhou promotes understory planting (8000 mu of hooked vine intercropping area) to achieve “no competition with people for food, no competition with food for land”.
5.4 Development prospects for the next decade
Based on the comprehensive industrial foundation and global trends, the golden window period for the internationalization of traditional Chinese medicine has arrived:
In terms of market size, it is expected that the global Chinese herbal medicine market will reach 350 billion yuan by 2030, and the proportion of organic herbs will increase to 40%.
In terms of regional expansion, ASEAN will become a gateway for traditional Chinese medicine to go global, and the China Cambodia Traditional Medicine Base will achieve mass production by 2027.
In terms of technological revolution: AI pharmaceutical platform accelerates formula optimization, and the first FDA approved innovative traditional Chinese medicine may appear in 2028.
The globalization of traditional Chinese medicine has entered a period of strategic opportunities. By upgrading the quality of the entire industry chain, deepening evidence-based medicine research, and innovating cross-cultural communication, traditional Chinese medicine will not only become an important pillar of the global health system, but also carry the unique contribution of Eastern wisdom to the “human health community”. All parties in the industry need to seize the historical opportunity of upgrading health consumption and empowering technology, and promote the flourishing of traditional Chinese medicine on the world stage.
